Cost effectiveness of alternative hepatitis A immunisation strategies.
van Doorslaer
E
E
Department of Epidemiology and Community Medicine, University of Antwerp, Belgium.
Tormans
G
G
van Damme
P
P
Beutels
P
P
D003362:Cost-Benefit Analysis; D006506:Hepatitis A / Q000191:economics / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007114:Immunization / Q000191:economics*; D012306:Risk